Orkin C, Arastéh K, Hernández-Mora MG et al. Long-acting cabotegravir + rilpivirine for hiv maintenance: FLAIR week 48 results. CROI 2019, abstract 140LB.
Behandeling van anale HSIL verlaagt risico anuscarcinoom
aug 2022 | HIV, Maag-darm-leveroncologie, Virale infecties